Kevin D. Bunker, Chief Operating Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 19,290 shares at $60.20 ($1.2M) on 2022-01-20, disclosed to the SEC on 2022-01-20.
Open-market sale of $1.2M ZNTL by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.17 | 2,753 | $163K | 14.1% |
| 2 | $59.17 | 2,753 | $163K | 14.1% |
| 3 | $60.20 | 6,537 | $394K | 34.0% |
| 4 | $60.20 | 6,537 | $394K | 34.0% |
| 5 | $61.29 | 710 | $44K | 3.8% |
| Total | $59.95 avg | 19,290 |
| $1.2M |
| 100% |
| Filing → |
| ZNTL | SELL | 2023-02-14 | $285K | — | Filing → |
| ZNTL | SELL | 2022-08-12 | $150K | — | Filing → |
| ZNTL | SELL | 2022-07-20 | $150K | — | Filing → |